| UniProt ID | PRDX5_HUMAN | |
|---|---|---|
| UniProt AC | P30044 | |
| Protein Name | Peroxiredoxin-5, mitochondrial | |
| Gene Name | PRDX5 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 214 | |
| Subcellular Localization |
Isoform Mitochondrial: Mitochondrion . Isoform Cytoplasmic+peroxisomal: Cytoplasm . Peroxisome matrix . Imported into peroxisomes via peroxisomal targeting signal 1 receptor PEX5. |
|
| Protein Description | Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. Plays a role in cell protection against oxidative stress by detoxifying peroxides and as sensor of hydrogen peroxide-mediated signaling events.. | |
| Protein Sequence | MGLAGVCALRRSAGYILVGGAGGQSAAAAARRYSEGEWASGGVRSFSRAAAAMAPIKVGDAIPAVEVFEGEPGNKVNLAELFKGKKGVLFGVPGAFTPGCSKTHLPGFVEQAEALKAKGVQVVACLSVNDAFVTGEWGRAHKAEGKVRLLADPTGAFGKETDLLLDDSLVSIFGNRRLKRFSMVVQDGIVKALNVEPDGTGLTCSLAPNIISQL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 12 | Phosphorylation | GVCALRRSAGYILVG HHHHHHHCCCEEEEE | 21.44 | 28555341 | |
| 31 (in isoform 2) | Ubiquitination | - | 33.09 | 21890473 | |
| 31 | Ubiquitination | QSAAAAARRYSEGEW HHHHHHHHHHCCCCC | 33.09 | 33845483 | |
| 34 | Phosphorylation | AAAARRYSEGEWASG HHHHHHHCCCCCCCC | 37.00 | 27251275 | |
| 34 | Ubiquitination | AAAARRYSEGEWASG HHHHHHHCCCCCCCC | 37.00 | 33845483 | |
| 45 | Phosphorylation | WASGGVRSFSRAAAA CCCCCHHHHHHHHHH | 25.76 | 32142685 | |
| 47 | Phosphorylation | SGGVRSFSRAAAAMA CCCHHHHHHHHHHCC | 23.43 | 17081983 | |
| 50 (in isoform 2) | Ubiquitination | - | 8.47 | 21890473 | |
| 50 | Ubiquitination | VRSFSRAAAAMAPIK HHHHHHHHHHCCCEE | 8.47 | 33845483 | |
| 57 | Ubiquitination | AAAMAPIKVGDAIPA HHHCCCEECCCEECE | 38.82 | 23503661 | |
| 64 | Ubiquitination | KVGDAIPAVEVFEGE ECCCEECEEEEECCC | 12.18 | 33845483 | |
| 75 | Acetylation | FEGEPGNKVNLAELF ECCCCCCEEEHHHHH | 38.11 | - | |
| 75 | Ubiquitination | FEGEPGNKVNLAELF ECCCCCCEEEHHHHH | 38.11 | 23503661 | |
| 83 | Acetylation | VNLAELFKGKKGVLF EEHHHHHCCCCEEEE | 80.56 | 19608861 | |
| 83 (in isoform 1) | Ubiquitination | - | 80.56 | 21890473 | |
| 83 | Succinylation | VNLAELFKGKKGVLF EEHHHHHCCCCEEEE | 80.56 | - | |
| 83 | Ubiquitination | VNLAELFKGKKGVLF EEHHHHHCCCCEEEE | 80.56 | 23000965 | |
| 83 | Ubiquitination | VNLAELFKGKKGVLF EEHHHHHCCCCEEEE | 80.56 | 21890473 | |
| 83 | Ubiquitination | VNLAELFKGKKGVLF EEHHHHHCCCCEEEE | 80.56 | 21890473 | |
| 83 | Succinylation | VNLAELFKGKKGVLF EEHHHHHCCCCEEEE | 80.56 | 23954790 | |
| 85 | Ubiquitination | LAELFKGKKGVLFGV HHHHHCCCCEEEEEC | 47.12 | 23000965 | |
| 86 | Ubiquitination | AELFKGKKGVLFGVP HHHHCCCCEEEEECC | 64.02 | 23000965 | |
| 97 | Ubiquitination | FGVPGAFTPGCSKTH EECCCCCCCCCCCCC | 20.45 | 24816145 | |
| 97 | Phosphorylation | FGVPGAFTPGCSKTH EECCCCCCCCCCCCC | 20.45 | 25159151 | |
| 100 | S-nitrosocysteine | PGAFTPGCSKTHLPG CCCCCCCCCCCCCCC | 3.87 | - | |
| 100 | Glutathionylation | PGAFTPGCSKTHLPG CCCCCCCCCCCCCCC | 3.87 | 22555962 | |
| 100 | S-nitrosylation | PGAFTPGCSKTHLPG CCCCCCCCCCCCCCC | 3.87 | 22178444 | |
| 100 | S-palmitoylation | PGAFTPGCSKTHLPG CCCCCCCCCCCCCCC | 3.87 | 29575903 | |
| 101 | Phosphorylation | GAFTPGCSKTHLPGF CCCCCCCCCCCCCCH | 46.64 | 28450419 | |
| 102 | Ubiquitination | AFTPGCSKTHLPGFV CCCCCCCCCCCCCHH | 44.00 | 21890473 | |
| 102 | Acetylation | AFTPGCSKTHLPGFV CCCCCCCCCCCCCHH | 44.00 | 25953088 | |
| 102 (in isoform 1) | Ubiquitination | - | 44.00 | 21890473 | |
| 116 | Ubiquitination | VEQAEALKAKGVQVV HHHHHHHHCCCCEEE | 55.91 | 33845483 | |
| 116 | Succinylation | VEQAEALKAKGVQVV HHHHHHHHCCCCEEE | 55.91 | - | |
| 116 | Malonylation | VEQAEALKAKGVQVV HHHHHHHHCCCCEEE | 55.91 | 26320211 | |
| 116 | Acetylation | VEQAEALKAKGVQVV HHHHHHHHCCCCEEE | 55.91 | 25038526 | |
| 116 | Succinylation | VEQAEALKAKGVQVV HHHHHHHHCCCCEEE | 55.91 | - | |
| 118 | Ubiquitination | QAEALKAKGVQVVAC HHHHHHCCCCEEEEE | 59.01 | - | |
| 142 | Ubiquitination | GEWGRAHKAEGKVRL CCCCCCCCCCCCEEE | 47.34 | 24816145 | |
| 146 | Ubiquitination | RAHKAEGKVRLLADP CCCCCCCCEEEEECC | 18.71 | 29967540 | |
| 159 | Ubiquitination | DPTGAFGKETDLLLD CCCCCCCCHHCEECC | 51.49 | 29967540 | |
| 159 | Acetylation | DPTGAFGKETDLLLD CCCCCCCCHHCEECC | 51.49 | 25038526 | |
| 161 | Phosphorylation | TGAFGKETDLLLDDS CCCCCCHHCEECCCH | 35.12 | 20873877 | |
| 168 | Phosphorylation | TDLLLDDSLVSIFGN HCEECCCHHHHHHCC | 30.27 | 28258704 | |
| 171 | Phosphorylation | LLDDSLVSIFGNRRL ECCCHHHHHHCCCCH | 19.93 | 25693802 | |
| 182 | Phosphorylation | NRRLKRFSMVVQDGI CCCHHHEEEEEECCC | 18.07 | 28450419 | |
| 183 | Sulfoxidation | RRLKRFSMVVQDGIV CCHHHEEEEEECCCE | 2.92 | 21406390 | |
| 204 | Glutathionylation | PDGTGLTCSLAPNII CCCCCEEEECCHHHH | 3.64 | 22555962 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PRDX5_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PRDX5_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PRDX5_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CC90B_HUMAN | CCDC90B | physical | 16169070 | |
| A4_HUMAN | APP | physical | 21832049 | |
| STAM1_HUMAN | STAM | physical | 22939629 | |
| SODC_HUMAN | SOD1 | physical | 22939629 | |
| VAMP2_HUMAN | VAMP2 | physical | 22939629 | |
| PRDX6_HUMAN | PRDX6 | physical | 22939629 | |
| SUMO1_HUMAN | SUMO1 | physical | 22939629 | |
| SC24A_HUMAN | SEC24A | physical | 22939629 | |
| PTN23_HUMAN | PTPN23 | physical | 22939629 | |
| SLD5_HUMAN | GINS4 | physical | 22939629 | |
| RS12_HUMAN | RPS12 | physical | 22939629 | |
| RD23B_HUMAN | RAD23B | physical | 22939629 | |
| TOM40_HUMAN | TOMM40 | physical | 22939629 | |
| UBE2B_HUMAN | UBE2B | physical | 22939629 | |
| UBAP2_HUMAN | UBAP2 | physical | 22939629 | |
| PTMS_HUMAN | PTMS | physical | 22939629 | |
| IFT27_HUMAN | IFT27 | physical | 22939629 | |
| PTGR1_HUMAN | PTGR1 | physical | 22939629 | |
| UBE2A_HUMAN | UBE2A | physical | 22939629 | |
| SSA27_HUMAN | SSSCA1 | physical | 22939629 | |
| ANCHR_HUMAN | ZFYVE19 | physical | 22939629 | |
| PSRC1_HUMAN | PSRC1 | physical | 22939629 | |
| DUT_HUMAN | DUT | physical | 26344197 | |
| NDKA_HUMAN | NME1 | physical | 26344197 | |
| PARK7_HUMAN | PARK7 | physical | 26344197 | |
| PRDX1_HUMAN | PRDX1 | physical | 26344197 | |
| PRDX2_HUMAN | PRDX2 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-83, AND MASS SPECTROMETRY. | |